HRI sheds light on the destructive impact of detention and incarceration on the health of people who use drugs and the need to divest from punitive approaches.
UNODC confirms that the synthetic drug market in East and Southeast Asia has adapted to setbacks brought on by Covid-19, with production and trafficking surging once again.
EHRA publishes the results of its survey on OST in order to develop practical recommendations that will help decision-makers and health providers to refine their approaches on the subject.
The 1st Brandenburg Forum provided a trusted space for important discussion and debate to strengthen the drug policy focus within the key health and human rights bodies in Geneva.
HIV Policy Lab has compiled a policy brief highlighting seven laws and policies that countries should adopt to markedly reduce AIDS-related mortality figures by 2030.
